Peroxisome proliferatoractivated receptorγ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus

Author：          

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|2|1877-1883

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.2, 2015-01, pp. : 1877-1883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor action of the peroxisome proliferatoractivated receptorγ agonist rosiglitazone in hepatocellular carcinoma

By          

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 1979-1984

Spandidos Publications

Access to resources Recommend Favorite

Resveratrol inhibits the phosphatidylinositide 3kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

By          

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2093-2098

Spandidos Publications

Access to resources Recommend Favorite

Effects of limiting energy availability via diet and physical activity on mammalian target of rapamycin-related signaling in rat mammary carcinomas

By Jiang Weiqin   Zhu Zongjian   Thompson Henry J.  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 378-387

Oxford University Press

Access to resources Recommend Favorite

Peroxisome proliferatoractivated receptorγ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP2 expression through PTEN

By        

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 6255-6260

Spandidos Publications

Access to resources Recommend Favorite

Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor-γ target genes

By          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 419-424

Spandidos Publications

Access to resources Recommend Favorite